TELA Bio, Inc. has approved equity compensation for three newly hired employees through restricted stock unit grants totaling 8,550 shares, according to an announcement citing Nasdaq Listing Rule 5635(c)(4). The grants were authorized by the company's Compensation Committee with a grant date of February 18, 2026, as part of the company's inducement equity package for new talent acquisition.
The restricted stock units will vest according to a standard four-year schedule, with equal annual installments contingent upon the recipients' continued employment with the company. This vesting structure aligns with typical equity compensation practices designed to promote employee retention and align incentives with long-term company performance.
Under Nasdaq Rule 5635(c)(4), companies may grant equity awards outside the standard stockholder approval framework when awards are granted in connection with new employee hiring. TELA Bio's use of this provision reflects common practice among publicly traded companies seeking to attract qualified personnel through equity-based compensation.